Artificial Intelligence Enhances NSCLC Care by Predicting Treatment Outcomes, Validating Neoadjuvant Therapies, and Improving Precision.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published Date:

Abstract

No abstract available for this article.

Authors

  • Shumpei Ishikawa
    Department of Preventive Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, 113-0033, Japan. ishum-prm@m.u-tokyo.ac.jp.